A 78-year-old woman presented with watery diarrhea and weight loss – 20 kg, 33% of body weight – in the previous 5 months. She denied fever or relevant epidemiological context. Her previous history was unremarkable.

Blood analysis showed anemia (hemoglobin 8.4 g/dL), leukocytosis with neutrophilia and high C-reactive protein (73.8 mg/L). Fecal analysis was negative for microbiological, parasitological and Giardia presence; fecal calprotectin was unchanged. Magnetic resonance enterography described normal small bowel and colon appearance, mesenteric fat densification and prominent mesenteric ganglia.

Upper endoscopy revealed enlarged duodenal folds, lymphangiectasias, focal hyperemia and friability of the duodenal mucosa (Fig. 1a, b). Ileocolonoscopy revealed continuous edema, hyperemia and friability of the distal ascending colon, associated with erosions and superficial ulcers, as well as a reduced distensibility (Fig. 2b, c). There were no endoscopic alterations in the remaining segments, including the terminal ileum (Fig. 2a). Histological examination of duodenal (Fig. 1c–e), ileal and ascending colonic samples (Fig. 2d–f) identified the presence of foamy macrophages, with periodic acid-Schiff (PAS)-positive intracytoplasmic granules, which were Ziehl-Neelsen-negative. Despite having no clinical neurological involvement, Tropheryma whipplei DNA was detected in the cerebrospinal fluid (CSF).

The patient completed a 14-day course of once daily 2 g intravenous ceftriaxone, followed by a 12-month course of twice daily 800 + 160 mg oral trimethoprim-sulfamethoxazole, which is currently under way. Diarrhea resolved in the first weeks of antibiotic therapy, and full weight recovery occurred after 4 months.

Whipple’s disease is a very rare and potentially fatal systemic disease. It usually develops over the course of many years in genetically predisposed patients. The classic presentation is characterized by diarrhea and weight loss, often preceded by joint complaints. Other symptoms include abdominal pain, low-grade fever and adenopathy. The diagnosis is based on characteristic findings in duodenal or jejunal biopsies. Although typical, the presence of foamy PAS-positive macrophages remains nonspecific and may be seen in other infections, particularly in immunocompromised patients, such as Mycobacterium avium, Rhodococcus equi, extrapulmonary pneumocystosis, leishmaniasis and histoplasmosis [1]. Ziehl staining is helpful to exclude Mycobacterium but a definite diagnosis implies T. whipplei identification by a second diagnostic test: immunohistochemistry or identification of bacterial DNA with polymerase chain reaction. The search for the bacteria in the CSF was of diagnostic value in our case. Yet, it is recommended in all cases to accurately evaluate central nervous system (CNS) involvement, which occurs in about half of the patients. In those cases, treatment should include an antibiotic with good penetration of the blood-brain barrier such as co-trimoxazole and should aim PCR negativity, since CNS disease may progress or relapse and is one of the major death causes [2].

Few works have addressed the endoscopic findings in Whipple’s disease, which are generally limited to the small bowel [3]. Colonic involvement was rarely described in the literature [4]. A very recent work reports the case of a child with chronic bloody diarrhea and an endoscopic appearance resembling ulcerative colitis, whose histological evaluation was diagnostic for Whipple’s disease [5]. In our work, we document small bowel mucosal appearance, as well as colonic endoscopic changes.

The authors declare that all ethical procedures were followed. Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

The authors have no conflicts of interest to declare.

There was no grant support for this study.

All authors fulfilled all 4 criteria of ICMJE for authorship: acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

1.
Sagaert
X
,
Tousseyn
T
,
De Hertogh
G
,
Geboes
K
.
Macrophage-related diseases of the gut: a pathologist’s perspective
.
Virchows Arch
.
2012
Jun
;
460
(
6
):
555
67
.
[PubMed]
1432-2307
2.
Marth
T
,
Moos
V
,
Müller
C
,
Biagi
F
,
Schneider
T
.
Tropheryma whipplei infection and Whipple’s disease
.
Lancet Infect Dis
.
2016
Mar
;
16
(
3
):
e13
22
.
[PubMed]
1474-4457
3.
Mönkemüller
K
,
Fry
LC
,
von Arnim
U
,
Neumann
H
,
Evert
M
,
Malfertheiner
P
.
Whipple’s disease: an endoscopic and histologic study
.
Digestion
.
2008
;
77
(
3-4
):
161
5
.
[PubMed]
1421-9867
4.
Marcial
MA
,
Villafaña
M
.
Whipple’s disease with esophageal and colonic involvement: endoscopic and histopathologic findings
.
Gastrointest Endosc
.
1997
Sep
;
46
(
3
):
263
6
.
[PubMed]
0016-5107
5.
Tatsuki
M
,
Ishige
T
,
Igarashi
Y
,
Hatori
R
,
Hokama
A
,
Hirato
J
, et al.
Whipple disease mimicking inflammatory bowel disease
.
Intest Res
.
2021
Jan
;
19
(
1
):
119
25
.
[PubMed]
1598-9100
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.